HMGCR and Parkinson disease: Finally, rare variant burden analysis revealed no significant association between HMGCR variants and either PD risk or AAO in either cohort and copy number variation analysis detected no clinically relevant duplications or deletions in the HMGCR gene region across all samples studied.